Main Menu

Hundreds of Years Combined Innovation Experience

Our Leaders

Our ability to launch new therapeutic solutions is supported by extensive leadership experience. Various team members have developed and/or launched successful products, including several that were first-in-class and/or reached iconic status. Our strategy leverages this relevant experience to meaningfully benefit underserved patients through the in-licensing, acquisition, development, and commercialization of innovative therapeutics.

Andrew Sklawer

Co-Founder, President & Chief Executive Officer

Andrew Sklawer
Andrew Sklawer

Andrew Sklawer

Co-Founder, President & Chief Executive Officer

Deepak Chadha

Chief R&D and Chief Operating Officer

Deepak Chadha, MS, MBA
Deepak Chadha, MS, MBA

Deepak Chadha

Chief R&D and Chief Operating Officer

Bert Marchio

Chief Financial Officer

Bert Marchio
Bert Marchio

Bert Marchio

Chief Financial Officer

David McAvoy

General Counsel & Chief Compliance Officer

David McAvoy, MSES, JD
David McAvoy, MSES, JD

David McAvoy

General Counsel & Chief Compliance Officer

Aron Aizenstat

Vice President, Corporate Development & Operations

Aron Aizenstat, MBA, PMP
Aron Aizenstat, MBA, PMP

Aron Aizenstat

Vice President, Corporate Development & Operations

Sue Fattor

Head of Human Resources

Sue Fattor
Sue Fattor

Sue Fattor

Head of Human Resources

Aaron Fox-Collis, CPA

Vice President, Finance & Chief Accounting Officer

Aaron Fox-Collis
Aaron Fox-Collis

Aaron Fox-Collis, CPA

Vice President, Finance & Chief Accounting Officer

James S. McElvain

Interim Head of CMC Development

James S. McElvain, PhD
James S. McElvain, PhD

James S. McElvain

Interim Head of CMC Development

Nancy Seretta

Vice President, Head of Clinical Operations

Nancy Seretta
Nancy Seretta

Nancy Seretta

Vice President, Head of Clinical Operations